Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Transl Res. 2016 Nov 1;182:1–13. doi: 10.1016/j.trsl.2016.10.010

Table 2.

Clinical Variables for each patient at Biopsy 1 and Biopsy 2

Patient
number		 Clinical
response
Group		 SCr at
flare
(mg/dl)		 Proteinuria
at flare
(g/d)		 Induction
therapy		 Maintenance
treatment		 SCr after
treatment
(mg/dl)		 Proteinuria
after
treatment
(g/d)		 Time to
Repeat
biopsy
1 CR 1.4 4.2 CYC1 N/A 0.7 0.2 6
2 CR 0.6 1.8 CYC N/A 0.8 0.2 6
3 CR 0.8 3.2 MMF2 Azathioprine 0.5 0.2 36
4 CR 1.1 2.0 MMF MMF 0.8 0.2 37
5 CR 0.8 4 MMF MMF 0.9 0.4 13
6 NR 0.8 6.0 CYC Azathioprine 1.1 3.5 28
7 NR 1.2 5.0 MMF N/A 1.4 2.8 6
8 NR 0.9 8.0 CYC N/A 0.7 5.0 10
9 NR 1.4 3.0 MMF MMF 1.5 2.0 15
1

CYC – Cyclophosphamide,

2

MMF – Mycophenolate Mofetil